Ariosa to price IPO of 3.5 million shares between $16.00 and $18.00

JPMorgan and Citigroup will be joint bookrunning managers for deal

By Devika Patel

Knoxville, Tenn., April 24 - Ariosa Diagnostics, Inc. will sell 3.5 million common shares in its initial public offering with a 30-day greenshoe for 525,000 additional shares, according to an S-1/A filed Thursday with the Securities and Exchange Commission. The deal was announced March 25.

The shares will be sold at a price expected to fall between $16.00 and $18.00.

Venrock Healthcare Capital Partners, LP and an affiliated fund have indicated they might invest up to about $10 million.

J.P. Morgan Securities LLC and Citigroup Global Markets Inc. are the joint bookrunning managers. Leerink Partners LLC and William Blair & Co., LLC are the co-managers.

Proceeds will be used for expansion, laboratory infrastructure and general corporate purposes.

The molecular diagnostics company is based in San Jose, Calif. The company intends to list its common stock on the Nasdaq Global Market under the symbol "AROS."

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.